Loading…
Novanta Inc. is projected to rise to $217.95 by 2027, a +35% move from its current price of $161.51. NOVT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $157.54 | $161.55 | $165.67 | +0.03% |
| May 30 | $155.94 | $161.59 | $167.45 | +0.05% |
| May 31 | $154.74 | $161.64 | $168.84 | +0.08% |
| Jun 1 | $153.74 | $161.68 | $170.03 | +0.10% |
| Jun 2 | $152.87 | $161.72 | $171.09 | +0.13% |
| Jun 3 | $152.09 | $161.76 | $172.05 | +0.16% |
| Jun 4 | $151.38 | $161.81 | $172.95 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $151.38 | $161.81 | $172.95 | +0.18% |
| Week 2 | $147.53 | $162.10 | $178.12 | +0.37% |
| Week 3 | $144.70 | $162.40 | $182.26 | +0.55% |
| Week 4 | $142.40 | $162.70 | $185.88 | +0.73% |
| Week 5 | $140.44 | $162.99 | $189.17 | +0.92% |
| Week 6 | $138.71 | $163.29 | $192.23 | +1.10% |
| Week 7 | $137.16 | $163.59 | $195.12 | +1.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Novanta Inc. is a Technology company that provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments.
The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications.
The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc.
in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Novanta Inc. is a technology-focused company that operates in precision medicine, precision manufacturing, medical solutions, robotics and automation, and advanced surgery technologies. The stock is currently priced at $159.70 and has a market cap of $5.69B, with a rank of 1253. The asset sits in the Technology category.
The price outlook is characterized by a bullish trajectory in the later forecast horizon, with year-by-year averages rising from the current level toward higher targets in 2030, 2040, and 2050, as indicated by the forecasted min, avg, and max figures and corresponding ROIs.
A major floor 34.3% below — a decisive break under it would weaken the trend.
The nearest floor, 25.2% below — buyers have tended to step in here.
Price is pressing into resistance (1.1% away) — a breakout level to watch.
A major ceiling 18.2% above — clearing it would confirm fresh momentum.
Key NOVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NOVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $158.60 | Buy | $158.96 | Buy |
| MA 10 | $155.60 | Buy | $154.93 | Buy |
| MA 20 | $145.26 | Buy | $148.21 | Buy |
| MA 50 | $131.99 | Buy | $138.53 | Buy |
| MA 100 | $133.12 | Buy | $132.90 | Buy |
| MA 200 | $123.58 | Buy | $129.86 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.95 | Neutral |
| Stoch RSI (14) | 57.03 | Neutral |
| CCI (20) | 92.38 | Neutral |
| Williams %R (14) | -6.59 | Info |
| MACD (12,26,9) | 1.20 | Buy |
| ROC (12) | 16.77 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 93.41 | Sell |
| TRIX (15) | 0.77 | Buy |
| Awesome (5,34) | 19.79 | Buy |
| Ultimate (7,14,28) | 68.96 | Neutral |
| Momentum (10) | 2.32 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 162.93 | Sell |
| ADX (14) | 26.79 | Buy |
| ATR (14) | 3.57 | Info |
The 30-day technical picture is bullish, with a sentiment reading of BULLISH and an RSI(14) of 70.
The moving-average backdrop shows a SMA50 of $130.19 and a SMA200 of $123.10, signaling positive momentum relative to longer-term trends. Support is identified at $120.89 and resistance at $159.70, framing a recent trading range within $134.31 to $189.89 over the past 30 days.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $111.14 | $161.51 | $250.36 | 0% | Neutral | |
| $174.16 | $217.95 | $288.15 | +35% | Bullish | |
| $193.39 | $248.09 | $339.09 | +54% | Bullish | |
| $212.47 | $278.28 | $390.52 | +72% | Bullish | |
| $213.99 | $285.46 | $409.67 | +77% | Bullish | |
| $242.71 | $329.24 | $481.85 | +104% | Bullish | |
| $290.32 | $400.01 | $595.85 | +148% | Bullish | |
| $328.10 | $458.71 | $694.34 | +184% | Bullish | |
| $354.11 | $502.00 | $771.19 | +211% | Bullish | |
| $351.84 | $505.45 | $787.24 | +213% | Bullish | |
| $529.01 | $807.02 | $1,331.81 | +400% | Bullish | |
| $1,003.74 | $1,696.73 | $3,048.00 | +951% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $111.14 | $161.51 | $189.73 | +0.00% |
| June 2026 | $137.76 | $161.51 | $193.65 | +0.00% |
| July 2026 | $139.99 | $165.40 | $200.80 | +2.41% |
| August 2026 | $147.94 | $175.85 | $215.54 | +6.32% |
| September 2026 | $152.22 | $181.85 | $224.64 | +3.41% |
| October 2026 | $153.41 | $184.12 | $229.05 | +1.25% |
| November 2026 | $158.78 | $191.34 | $239.51 | +3.92% |
| December 2026 | $164.38 | $198.85 | $250.36 | +3.92% |
Click any year to see its month-by-month NOVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NOVT price prediction for 2026 points to an average of $161.51 (low $111.14, high $250.36) — a potential gain of 0% on today's $161.51. Price action looks broadly range-bound.
In 2027, NOVT is projected to trade between $174.16 and $288.15, averaging $217.95 — a potential gain of +35% from today's $161.51. That is up +35% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Novanta Inc.'s 2028 outlook centres on $248.09, within a $193.39 to $339.09 range. That is up +14% on the projected 2027 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2029, NOVT could reach as high as $390.52, with a base case around $278.28 and support toward $212.47 — roughly +72% from $161.51. Buyers look set to stay in control over this stretch.
Expect NOVT to range from $213.99 to $409.67 through 2030. The $285.46 average target implies a +77% move from current prices. That is up +3% on the projected 2029 average. Momentum favours further upside here.
The NOVT price prediction for 2031 points to an average of $329.24 (low $242.71, high $481.85) — a potential gain of +104% on today's $161.51. Buyers look set to stay in control over this stretch.
In 2032, NOVT is projected to trade between $290.32 and $595.85, averaging $400.01 — a potential gain of +148% from today's $161.51. That is up +21% on the projected 2031 average. Momentum favours further upside here.
Novanta Inc.'s 2033 outlook centres on $458.71, within a $328.10 to $694.34 range. That is up +15% on the projected 2032 average. That marks a +184% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NOVT could reach as high as $771.19, with a base case around $502.00 and support toward $354.11 — roughly +211% from $161.51. Momentum favours further upside here.
Expect NOVT to range from $351.84 to $787.24 through 2035. The $505.45 average target implies a +213% move from current prices. That is up +1% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The NOVT price prediction for 2040 points to an average of $807.02 (low $529.01, high $1,331.81) — a potential gain of +400% on today's $161.51. Momentum favours further upside here.
In 2050, NOVT is projected to trade between $1,003.74 and $3,048.00, averaging $1,696.73 — a potential gain of +951% from today's $161.51. That is up +110% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NOVT today (≈ 6.191567 NOVT) could be worth
$10,505.4
+$9,505.4 (+951%) by 2050 · US Dollar
Based on the average projected NOVT price of $1,696.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NOVTwould be worth at today's price.
$1,000 invested in NOVT on May 27, 2025 (≈ 8.108985 NOVT) would be worth
$1,309.68
+$309.68 (+31.0%) today · 1.31× · US Dollar
Based on a NOVT entry price of $123.32 vs. today's $161.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $153.6 | $1,051.5 | +5.1% |
| 1 month ago | $132.78 | $1,216.37 | +21.6% |
| 3 months ago | $136.64 | $1,182.01 | +18.2% |
| 6 months ago | $113.66 | $1,420.99 | +42.1% |
| 1 year ago | $123.32 | $1,309.68 | +31.0% |
| All time (5.0y) ago | $138.96 | $1,162.28 | +16.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NOVT forecast.
Our base-case forecast reaches $320.00 around 2031.
Implied market cap at $320.00: $11.4B
The multi-year forecast presents a rising trajectory with clear bullish sentiment across the horizon. In 2026, the average price is $159.70 with a 0% ROI and neutral sentiment. By 2027, the average climbs to $215.46 (ROI 34.9%, bullish), and by 2028 to $247.29 (ROI 54.9%, bullish).
In 2029 the average is $276.23 (ROI 73%, bullish), and in 2030 the average is $280.01 (ROI 75.3%, bullish). The forecast continues higher through 2031 ($326.78 avg, ROI 104.6%), 2032 ($397.67 avg, ROI 149%), 2033 ($453.93 avg, ROI 184.2%), 2034 ($499.92 avg, ROI 213%), and 2035 ($498.37 avg, ROI 212.1%). The long-horizon view shows a strong rise to 2040 ($804.30 avg, ROI 403.6%, bullish) and to 2050 ($1,679.34 avg, ROI 951.6%, bullish).
These figures are estimates and carry uncertainty; actual outcomes may differ, and there are no guarantees.
Tap a question to reveal the answer.
The average price is $280.01 with a range of $208.40 to $405.30; ROI is 75.3% and sentiment is BULLISH.
Forecasts show bullish sentiment from 2027 onward, with the average price rising from $215.46 (2027) to $280.01 (2030) and higher in 2040 ($804.30) and 2050 ($1,679.34); ROIs rise to 34.9% in 2027 and to 951.6% in 2050.
Yes. The forecast max reaches $1,344.58 in 2040 and $3,063.34 in 2050, indicating potential to exceed $1,000.
Current price is $159.70, market cap $5.69B, and rank 1253.
Average price is $159.70 with a range of $111.14 to $250.38; sentiment is NEUTRAL and ROI is 0%.
Novanta Inc. Community Discussion
0Share your Novanta Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.